» Articles » PMID: 35163236

Toward Xeno-Free Differentiation of Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163236
Authors
Affiliations
Soon will be listed here.
Abstract

The small intestinal epithelium has an important role in nutrition, but also in drug absorption and metabolism. There are a few two-dimensional (2D) patient-derived induced pluripotent stem cell (iPSC)-based intestinal models enabling easy evaluation of transcellular transport. It is known that animal-derived components induce variation in the experimental outcomes. Therefore, we aimed to refine the differentiation protocol by using animal-free components. More specifically, we compared maturation of 2D-cultured iPCSs toward small intestinal epithelial cells when cultured either with or without serum, and either on Geltrex or on animal-free, recombinant laminin-based substrata. Differentiation status was characterized by qPCR, immunofluorescence imaging, and functionality assays. Our data suggest that differentiation toward definitive endoderm is more efficient without serum. Both collagen- and recombinant laminin-based coating supported differentiation of definitive endoderm, posterior definitive endoderm, and small intestinal epithelial cells from iPS-cells equally well. Small intestinal epithelial cells differentiated on recombinant laminin exhibited slightly more enterocyte specific cellular functionality than cells differentiated on Geltrex. Our data suggest that functional small intestinal epithelial cells can be generated from iPSCs in serum-free method on xeno-free substrata. This method is easily converted to an entirely xeno-free method.

Citing Articles

iPSC-derived cells for whole liver bioengineering.

Telles-Silva K, Pacheco L, Chianca F, Komatsu S, Chiovatto C, Zatz M Front Bioeng Biotechnol. 2024; 12:1338762.

PMID: 38384436 PMC: 10879941. DOI: 10.3389/fbioe.2024.1338762.


Differentiating Human Pluripotent Stem Cells to Cardiomyocytes Using Purified Extracellular Matrix Proteins.

Barnes A, Holmstoen T, Bonham A, Rowland T Bioengineering (Basel). 2022; 9(12).

PMID: 36550926 PMC: 9774171. DOI: 10.3390/bioengineering9120720.

References
1.
Ogaki S, Morooka M, Otera K, Kume S . A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells. Sci Rep. 2015; 5:17297. PMC: 4663490. DOI: 10.1038/srep17297. View

2.
Eneroth A, Astrom E, Hoogstraate J, Schrenk D, Conrad S, Kauffmann H . Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur J Pharm Sci. 2000; 12(3):205-14. DOI: 10.1016/s0928-0987(00)00117-2. View

3.
Aldhous M, Shmakov A, Bode J, Ghosh S . Characterization of conditions for the primary culture of human small intestinal epithelial cells. Clin Exp Immunol. 2001; 125(1):32-40. PMC: 1906094. DOI: 10.1046/j.1365-2249.2001.01522.x. View

4.
Sato T, Vries R, Snippert H, van de Wetering M, Barker N, Stange D . Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459(7244):262-5. DOI: 10.1038/nature07935. View

5.
Kodama N, Iwao T, Katano T, Ohta K, Yuasa H, Matsunaga T . Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. Drug Metab Dispos. 2016; 44(10). DOI: 10.1124/dmd.116.069336. View